VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q62138580 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010732.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q62138580‏
024 ‎‡a 0000-0001-8663-6525‏ ‎‡2 orcid‏
024 ‎‡a 7005253998‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q62138580‏
100 0 ‎‡a M Francesca Cordeiro‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a M Francesca Cordeiro‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)‏
670 ‎‡a Author's A semi-automated technique for labeling and counting of apoptosing retinal cells.‏
670 ‎‡a Author's Accuracy of intraocular pressure measurements in new zealand white rabbits‏
670 ‎‡a Author's Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.‏
670 ‎‡a Author's Advances in retinal ganglion cell imaging‏
670 ‎‡a Author's Alzheimer's disease and retinal neurodegeneration.‏
670 ‎‡a Author's Annexins in Glaucoma.‏
670 ‎‡a Author's Assessment of neuroprotection in the retina with DARC.‏
670 ‎‡a Author's Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes‏
670 ‎‡a Author's Back to basics - ephrins, axonal guidance, neuroprotection and glaucoma‏
670 ‎‡a Author's Changes in the modulation of retinocollicular transmission through group III mGluRs long after an increase in intraocular pressure in a rat model of glaucoma‏
670 ‎‡a Author's Clinical evidence for neuroprotection in glaucoma.‏
670 ‎‡a Author's Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma.‏
670 ‎‡a Author's Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial.‏
670 ‎‡a Author's Current perspective of neuroprotection and glaucoma‏
670 ‎‡a Author's Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.‏
670 ‎‡a Author's Dendritic changes in rat visual pathway associated with experimental ocular hypertension‏
670 ‎‡a Author's Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions.‏
670 ‎‡a Author's Direct optic nerve sheath‏
670 ‎‡a Author's Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo‏
670 ‎‡a Author's Dynamic changes in cell size and corresponding cell fate after optic nerve injury‏
670 ‎‡a Author's Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma‏
670 ‎‡a Author's Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit‏
670 ‎‡a Author's Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol‏
670 ‎‡a Author's Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.‏
670 ‎‡a Author's Electroretinogram as indicator of prognosis of central retinal vein occlusion.‏
670 ‎‡a Author's En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma.‏
670 ‎‡a Author's Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.‏
670 ‎‡a Author's Focus on: amyloid beta.‏
670 ‎‡a Author's Glaucoma: the retina and beyond‏
670 ‎‡a Author's High-resolution ocular imaging: combining advanced optics and microtechnology‏
670 ‎‡a Author's Human antitransforming growth factor beta‏
670 ‎‡a Author's Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study‏
670 ‎‡a Author's Imaging apoptosis in the eye.‏
670 ‎‡a Author's [In vivo imaging of retinal cell apoptosis following acute light exposure].‏
670 ‎‡a Author's Integration of paper microfluidic sensors into contact lenses for tear fluid analysis‏
670 ‎‡a Author's Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus‏
670 ‎‡a Author's Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging‏
670 ‎‡a Author's Modulation of wound healing after glaucoma surgery.‏
670 ‎‡a Author's Neuroprotection in glaucoma: drug-based approaches.‏
670 ‎‡a Author's Neuroprotection in glaucoma – Is there a future role?‏
670 ‎‡a Author's Neuroprotection in glaucoma: old concepts, new ideas‏
670 ‎‡a Author's New Concepts: Manipulation of the Wound-Healing Response‏
670 ‎‡a Author's Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.‏
670 ‎‡a Author's Ocular manifestations of Alzheimer's disease in animal models.‏
670 ‎‡a Author's Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers‏
670 ‎‡a Author's Optical coherence tomography in anterior segment imaging.‏
670 ‎‡a Author's Predicting wet age-related macular degeneration (AMD) using DARC (Detecting Apoptosing Retinal Cells) AI (artificial intelligence) technology‏
670 ‎‡a Author's Preservative-free treatment in glaucoma: who, when, and why.‏
670 ‎‡a Author's Purification of annexin V and its use in the detection of apoptotic cells.‏
670 ‎‡a Author's Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy‏
670 ‎‡a Author's Real-Time Imaging of Retinal Ganglion Cell Apoptosis.‏
670 ‎‡a Author's Retinal correlates of neurological disorders‏
670 ‎‡a Author's Retinal correlates of psychiatric disorders‏
670 ‎‡a Author's Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.‏
670 ‎‡a Author's Retinal manifestations of Alzheimer's disease‏
670 ‎‡a Author's Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma‏
670 ‎‡a Author's Targeting amyloid-beta in glaucoma treatment.‏
670 ‎‡a Author's The effect of formal instruction in ophthalmoscopy on medical student performance‏
670 ‎‡a Author's The role of the immune system in conjunctival wound healing after glaucoma surgery.‏
670 ‎‡a Author's Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.‏
670 ‎‡a Author's Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes‏
670 ‎‡a Author's Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration‏
670 ‎‡a Author's Understanding and controlling the scarring response: the contribution of histology and microscopy‏
670 ‎‡a Author's Unexpected low-dose toxicity of the universal solvent DMSO.‏
670 ‎‡a Author's Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression‏
909 ‎‡a (scopus) 7005253998‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000186636525‏ ‎‡9 1‏
919 ‎‡a localisationandsignificanceofinvivonearinfraredautofluorescentsignalinretinalimaging‏ ‎‡A Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging‏ ‎‡9 1‏
919 ‎‡a opticalcoherencetomographyinanteriorsegmentimaging‏ ‎‡A Optical coherence tomography in anterior segment imaging.‏ ‎‡9 1‏
919 ‎‡a visualandocularmanifestationsofalzheimersdiseaseandtheiruseasbiomarkersfordiagnosisandprogression‏ ‎‡A Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression‏ ‎‡9 1‏
919 ‎‡a unexpectedlowdosetoxicityoftheuniversalsolventdmso‏ ‎‡A Unexpected low-dose toxicity of the universal solvent DMSO.‏ ‎‡9 1‏
919 ‎‡a understandingandcontrollingthescarringresponsethecontributionofhistologyandmicroscopy‏ ‎‡A Understanding and controlling the scarring response: the contribution of histology and microscopy‏ ‎‡9 1‏
919 ‎‡a topicalrecombinanthumannervegrowthfactorrhngfisneuroprotectivetoretinalganglioncellsbytargetingsecondarydegeneration‏ ‎‡A Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration‏ ‎‡9 1‏
919 ‎‡a topicaldeliveryofavastintotheposteriorsegmentoftheeyeinvivousingannexina5associatedliposomes‏ ‎‡A Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes‏ ‎‡9 1‏
919 ‎‡a topicalcoenzymeq10demonstratesmitochondrialmediatedneuroprotectioninarodentmodelofocularhypertension‏ ‎‡A Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.‏ ‎‡9 1‏
919 ‎‡a roleoftheimmunesysteminconjunctivalwoundhealingafterglaucomasurgery‏ ‎‡A The role of the immune system in conjunctival wound healing after glaucoma surgery.‏ ‎‡9 1‏
919 ‎‡a effectofformalinstructioninophthalmoscopyonmedicalstudentperformance‏ ‎‡A The effect of formal instruction in ophthalmoscopy on medical student performance‏ ‎‡9 1‏
919 ‎‡a targetingamyloidbetainglaucomatreatment‏ ‎‡A Targeting amyloid-beta in glaucoma treatment.‏ ‎‡9 1‏
919 ‎‡a simultaneouscodeliveryofneuroprotectivedrugsfrommultiloadedplgamicrospheresforthetreatmentofglaucoma‏ ‎‡A Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma‏ ‎‡9 1‏
919 ‎‡a retinalmanifestationsofalzheimersdisease‏ ‎‡A Retinal manifestations of Alzheimer's disease‏ ‎‡9 1‏
919 ‎‡a retinalganglioncellapoptosisinglaucomaisrelatedtointraocularpressureandiopinducedeffectsonextracellularmatrix‏ ‎‡A Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix.‏ ‎‡9 1‏
919 ‎‡a retinalcorrelatesofpsychiatricdisorders‏ ‎‡A Retinal correlates of psychiatric disorders‏ ‎‡9 1‏
919 ‎‡a retinalcorrelatesofneurologicaldisorders‏ ‎‡A Retinal correlates of neurological disorders‏ ‎‡9 1‏
919 ‎‡a purificationofannexin5anditsuseinthedetectionofapoptoticcells‏ ‎‡A Purification of annexin V and its use in the detection of apoptotic cells.‏ ‎‡9 1‏
919 ‎‡a preservativefreetreatmentinglaucomawhowhenandwhy‏ ‎‡A Preservative-free treatment in glaucoma: who, when, and why.‏ ‎‡9 1‏
919 ‎‡a predictingwetagerelatedmaculardegenerationamdusingdarcdetectingapoptosingretinalcellsaiartificialintelligencetechnology‏ ‎‡A Predicting wet age-related macular degeneration (AMD) using DARC (Detecting Apoptosing Retinal Cells) AI (artificial intelligence) technology‏ ‎‡9 1‏
919 ‎‡a oculovisualabnormalitiesinparkinsonsdiseasepossiblevalueasbiomarkers‏ ‎‡A Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers‏ ‎‡9 1‏
919 ‎‡a ocularmanifestationsofalzheimersdiseaseinanimalmodels‏ ‎‡A Ocular manifestations of Alzheimer's disease in animal models.‏ ‎‡9 1‏
919 ‎‡a novelantisenseoligonucleotidestargetingtgfbetainhibitinvivoscarringandimprovesurgicaloutcome‏ ‎‡A Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome.‏ ‎‡9 1‏
919 ‎‡a newconceptsmanipulationofthewoundhealingresponse‏ ‎‡A New Concepts: Manipulation of the Wound-Healing Response‏ ‎‡9 1‏
919 ‎‡a neuroprotectioninglaucomaoldconceptsnewideas‏ ‎‡A Neuroprotection in glaucoma: old concepts, new ideas‏ ‎‡9 1‏
919 ‎‡a neuroprotectioninglaucomaisthereafuturerole‏ ‎‡A Neuroprotection in glaucoma – Is there a future role?‏ ‎‡9 1‏
919 ‎‡a neuroprotectioninglaucomadrugbasedapproaches‏ ‎‡A Neuroprotection in glaucoma: drug-based approaches.‏ ‎‡9 1‏
919 ‎‡a modulationofwoundhealingafterglaucomasurgery‏ ‎‡A Modulation of wound healing after glaucoma surgery.‏ ‎‡9 1‏
919 ‎‡a ischaemicopticneuropathytransversemyelitisandepilepsyinanantiphospholipidpositivepatientwithsystemiclupuserythematosus‏ ‎‡A Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus‏ ‎‡9 1‏
919 ‎‡a integrationofpapermicrofluidicsensorsintocontactlensesfortearfluidanalysis‏ ‎‡A Integration of paper microfluidic sensors into contact lenses for tear fluid analysis‏ ‎‡9 1‏
919 ‎‡a invivoimagingofretinalcellapoptosisfollowingacutelightexposure‏ ‎‡A [In vivo imaging of retinal cell apoptosis following acute light exposure].‏ ‎‡9 1‏
919 ‎‡a imagingapoptosisintheeye‏ ‎‡A Imaging apoptosis in the eye.‏ ‎‡9 1‏
919 ‎‡a humanantitransforminggrowthfactorbeta2monoclonalantibodyanewmodulatorofwoundhealingintrabeculectomyarandomizedplacebocontrolledclinicalstudy‏ ‎‡A Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study‏ ‎‡9 1‏
919 ‎‡a humanantitransforminggrowthfactorbeta‏ ‎‡A Human antitransforming growth factor beta‏ ‎‡9 1‏
919 ‎‡a highresolutionocularimagingcombiningadvancedopticsandmicrotechnology‏ ‎‡A High-resolution ocular imaging: combining advanced optics and microtechnology‏ ‎‡9 1‏
919 ‎‡a glaucomatheretinaandbeyond‏ ‎‡A Glaucoma: the retina and beyond‏ ‎‡9 1‏
919 ‎‡a focusonamyloidbeta‏ ‎‡A Focus on: amyloid beta.‏ ‎‡9 1‏
919 ‎‡a evaluationofantitgfbeta2antibodyasanewpostoperativeantiscarringagentinglaucomasurgery‏ ‎‡A Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.‏ ‎‡9 1‏
919 ‎‡a faceopticalcoherencetomographyanewmethodtoanalysestructuralchangesoftheopticnerveheadinratglaucoma‏ ‎‡A En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma.‏ ‎‡9 1‏
919 ‎‡a electroretinogramasindicatorofprognosisofcentralretinalveinocclusion‏ ‎‡A Electroretinogram as indicator of prognosis of central retinal vein occlusion.‏ ‎‡9 1‏
919 ‎‡a efficacyofapreservativefreeformulationoffixedcombinationbimatoprostandtimololganfortpfintreatmentnaivepatientsvspreviouslytreatedpatients‏ ‎‡A Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (Ganfort PF) in treatment-naïve patients vs previously treated patients.‏ ‎‡9 1‏
919 ‎‡a efficacyofapreservativefreeformulationoffixedcombinationbimatoprostandtimolol‏ ‎‡A Efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol‏ ‎‡9 1‏
919 ‎‡a effectofvaryingthemitomycin100treatmentareainglaucomafiltrationsurgeryintherabbit‏ ‎‡A Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit‏ ‎‡9 1‏
919 ‎‡a effectoftheaβaggregationmodulatormrz99030onretinaldamageinananimalmodelofglaucoma‏ ‎‡A Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma‏ ‎‡9 1‏
919 ‎‡a dynamicchangesincellsizeandcorrespondingcellfateafteropticnerveinjury‏ ‎‡A Dynamic changes in cell size and corresponding cell fate after optic nerve injury‏ ‎‡9 1‏
919 ‎‡a directopticnervesheathdonsapplicationofschwanncellsprolongsretinalganglioncellsurvivalinvivo‏ ‎‡A Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo‏ ‎‡9 1‏
919 ‎‡a directopticnervesheath‏ ‎‡A Direct optic nerve sheath‏ ‎‡9 1‏
919 ‎‡a dendriticchangesinvisualpathwaysinglaucomaandotherneurodegenerativeconditions‏ ‎‡A Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions.‏ ‎‡9 1‏
919 ‎‡a dendriticchangesinratvisualpathwayassociatedwithexperimentalocularhypertension‏ ‎‡A Dendritic changes in rat visual pathway associated with experimental ocular hypertension‏ ‎‡9 1‏
919 ‎‡a cysticblebformationandrelatedcomplicationsinlimbusversusfornixbasedconjunctivalflapsinpediatricandyoungadulttrabeculectomywithmitomycin100‏ ‎‡A Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C.‏ ‎‡9 1‏
919 ‎‡a currentperspectiveofneuroprotectionandglaucoma‏ ‎‡A Current perspective of neuroprotection and glaucoma‏ ‎‡9 1‏
919 ‎‡a comparisonofpreservativefreelatanoprostandpreservativefreebimatoprostinamulticenterrandomizedinvestigatormaskedcrossoverclinicaltrialthesporttrial‏ ‎‡A Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial.‏ ‎‡9 1‏
919 ‎‡a combiningphacoemulsificationwithendoscopiccyclophotocoagulationtomanagecataractandglaucoma‏ ‎‡A Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma.‏ ‎‡9 1‏
919 ‎‡a clinicalevidenceforneuroprotectioninglaucoma‏ ‎‡A Clinical evidence for neuroprotection in glaucoma.‏ ‎‡9 1‏
919 ‎‡a changesinthemodulationofretinocolliculartransmissionthroughgroup3mglurslongafteranincreaseinintraocularpressureinaratmodelofglaucoma‏ ‎‡A Changes in the modulation of retinocollicular transmission through group III mGluRs long after an increase in intraocular pressure in a rat model of glaucoma‏ ‎‡9 1‏
919 ‎‡a backtobasicsephrinsaxonalguidanceneuroprotectionandglaucoma‏ ‎‡A Back to basics - ephrins, axonal guidance, neuroprotection and glaucoma‏ ‎‡9 1‏
919 ‎‡a assessmentofratandmousergcapoptosisimaginginvivowithdifferentscanninglaserophthalmoscopes‏ ‎‡A Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes‏ ‎‡9 1‏
919 ‎‡a assessmentofneuroprotectionintheretinawithdarc‏ ‎‡A Assessment of neuroprotection in the retina with DARC.‏ ‎‡9 1‏
919 ‎‡a annexinsinglaucoma‏ ‎‡A Annexins in Glaucoma.‏ ‎‡9 1‏
919 ‎‡a alzheimersdiseaseandretinalneurodegeneration‏ ‎‡A Alzheimer's disease and retinal neurodegeneration.‏ ‎‡9 1‏
919 ‎‡a advancesinretinalganglioncellimaging‏ ‎‡A Advances in retinal ganglion cell imaging‏ ‎‡9 1‏
919 ‎‡a adenosinea3receptoractivationisneuroprotectiveagainstretinalneurodegeneration‏ ‎‡A Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.‏ ‎‡9 1‏
919 ‎‡a accuracyofintraocularpressuremeasurementsinnewzealandwhiterabbits‏ ‎‡A Accuracy of intraocular pressure measurements in new zealand white rabbits‏ ‎‡9 1‏
919 ‎‡a semiautomatedtechniqueforlabelingandcountingofapoptosingretinalcells‏ ‎‡A A semi-automated technique for labeling and counting of apoptosing retinal cells.‏ ‎‡9 1‏
919 ‎‡a cnnaidedmethodtopredictglaucomaprogressionusingdarcdetectionofapoptosingretinalcells‏ ‎‡A A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)‏ ‎‡9 1‏
919 ‎‡a realtimeimagingofretinalcellapoptosisbyconfocalscanninglaserophthalmoscopy‏ ‎‡A Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy‏ ‎‡9 1‏
919 ‎‡a realtimeimagingofretinalganglioncellapoptosis‏ ‎‡A Real-Time Imaging of Retinal Ganglion Cell Apoptosis.‏ ‎‡9 1‏
996 ‎‡2 PTBNP|191126‏
996 ‎‡2 LC|no2008081173‏
996 ‎‡2 DNB|1110801750‏
996 ‎‡2 ISNI|0000000358111646‏
996 ‎‡2 BLBNB|000618252‏
996 ‎‡2 LC|n 2013184270‏
996 ‎‡2 ISNI|0000000069907760‏
996 ‎‡2 PTBNP|75430‏
996 ‎‡2 BLBNB|000165174‏
996 ‎‡2 LC|nb2012000588‏
996 ‎‡2 PTBNP|128247‏
996 ‎‡2 BLBNB|000165170‏
996 ‎‡2 BLBNB|000165171‏
996 ‎‡2 LC|n 2013035686‏
996 ‎‡2 LC|n 2020021862‏
996 ‎‡2 ISNI|0000000028716714‏
996 ‎‡2 ISNI|0000000079969690‏
996 ‎‡2 ISNI|0000000078035634‏
996 ‎‡2 SUDOC|26842974X‏
996 ‎‡2 LC|n 85130655‏
996 ‎‡2 LC|n 2006218332‏
996 ‎‡2 ISNI|0000000062526324‏
996 ‎‡2 LC|n 82135838‏
996 ‎‡2 LC|n 2023255784‏
996 ‎‡2 ISNI|0000000069613455‏
996 ‎‡2 ISNI|0000000067752398‏
996 ‎‡2 DNB|1060695006‏
996 ‎‡2 PTBNP|26546‏
996 ‎‡2 NUKAT|n 2010131503‏
996 ‎‡2 PTBNP|23883‏
996 ‎‡2 PTBNP|1838764‏
996 ‎‡2 ISNI|0000000070981837‏
996 ‎‡2 BLBNB|000394717‏
996 ‎‡2 SUDOC|156275708‏
996 ‎‡2 ISNI|0000000093758224‏
996 ‎‡2 BNE|XX852190‏
996 ‎‡2 ISNI|0000000428172971‏
996 ‎‡2 DBC|870979138858863‏
996 ‎‡2 PTBNP|35478‏
996 ‎‡2 LC|n 2009213698‏
996 ‎‡2 JPG|500292199‏
996 ‎‡2 PTBNP|50358‏
996 ‎‡2 PTBNP|157772‏
996 ‎‡2 LNB|LNC10-000244885‏
996 ‎‡2 ISNI|0000000034233954‏
996 ‎‡2 BNE|XX1142765‏
996 ‎‡2 SUDOC|202362647‏
996 ‎‡2 PTBNP|285661‏
996 ‎‡2 ISNI|0000000108769795‏
996 ‎‡2 LC|no2013081913‏
996 ‎‡2 ISNI|0000000427577555‏
996 ‎‡2 SUDOC|068956533‏
996 ‎‡2 BNE|XX5861137‏
996 ‎‡2 ISNI|0000000068992844‏
996 ‎‡2 PTBNP|78852‏
996 ‎‡2 PTBNP|1921329‏
996 ‎‡2 BLBNB|000520036‏
996 ‎‡2 BLBNB|000165187‏
996 ‎‡2 RERO|A006107127‏
996 ‎‡2 DNB|1339387239‏
996 ‎‡2 PTBNP|1785972‏
996 ‎‡2 ISNI|0000000068604311‏
996 ‎‡2 SUDOC|271079444‏
996 ‎‡2 ISNI|0000000454381814‏
996 ‎‡2 ISNI|0000000410108912‏
996 ‎‡2 PTBNP|1230095‏
996 ‎‡2 ICCU|LO1V304862‏
996 ‎‡2 LC|n 2024022076‏
996 ‎‡2 PTBNP|1881086‏
996 ‎‡2 BNE|XX1554033‏
996 ‎‡2 LC|n 2024253650‏
996 ‎‡2 BLBNB|000165173‏
996 ‎‡2 PTBNP|221825‏
996 ‎‡2 LC|no2016005514‏
996 ‎‡2 ISNI|0000000069307650‏
996 ‎‡2 ISNI|0000000068476495‏
996 ‎‡2 PTBNP|1148290‏
996 ‎‡2 BNE|XX1135796‏
996 ‎‡2 ISNI|0000000036708570‏
996 ‎‡2 ISNI|0000000069296103‏
996 ‎‡2 LC|n 2020251234‏
996 ‎‡2 ISNI|0000000079599773‏
996 ‎‡2 ISNI|0000000396948412‏
996 ‎‡2 ISNI|0000000069522991‏
996 ‎‡2 BLBNB|001126871‏
996 ‎‡2 PTBNP|211411‏
996 ‎‡2 DNB|139412808‏
996 ‎‡2 PTBNP|1652789‏
996 ‎‡2 BLBNB|001133598‏
996 ‎‡2 PTBNP|1544053‏
996 ‎‡2 ISNI|000000006858957X‏
996 ‎‡2 BNF|16645822‏
996 ‎‡2 PTBNP|1342014‏
996 ‎‡2 RERO|A014022854‏
996 ‎‡2 BNF|16960174‏
996 ‎‡2 PTBNP|1277061‏
996 ‎‡2 BLBNB|000203556‏
996 ‎‡2 LC|no2015098363‏
996 ‎‡2 LC|no2010087581‏
996 ‎‡2 ISNI|0000000069323079‏
996 ‎‡2 SUDOC|196155428‏
996 ‎‡2 PTBNP|979582‏
996 ‎‡2 PTBNP|50502‏
996 ‎‡2 PTBNP|1669277‏
996 ‎‡2 PTBNP|1300221‏
996 ‎‡2 BLBNB|000331132‏
996 ‎‡2 ISNI|0000000067560476‏
996 ‎‡2 BLBNB|000423024‏
996 ‎‡2 PTBNP|50509‏
996 ‎‡2 BLBNB|000535417‏
996 ‎‡2 ISNI|0000000037488856‏
996 ‎‡2 PTBNP|1453788‏
996 ‎‡2 CAOONL|ncf10461313‏
996 ‎‡2 PTBNP|1833758‏
996 ‎‡2 PTBNP|1681528‏
996 ‎‡2 ISNI|0000000071501559‏
996 ‎‡2 LC|n 2012213357‏
996 ‎‡2 PTBNP|66766‏
996 ‎‡2 PTBNP|1832349‏
996 ‎‡2 BLBNB|000492778‏
996 ‎‡2 DNB|126887650X‏
996 ‎‡2 LC|n 85353385‏
996 ‎‡2 ISNI|0000000410033818‏
996 ‎‡2 PTBNP|1704912‏
996 ‎‡2 BLBNB|001531760‏
996 ‎‡2 LC|n 88290885‏
996 ‎‡2 PTBNP|1709497‏
996 ‎‡2 N6I|vtls000054972‏
996 ‎‡2 ISNI|0000000068409436‏
996 ‎‡2 BLBNB|000560904‏
996 ‎‡2 PTBNP|77457‏
996 ‎‡2 LC|n 87870427‏
996 ‎‡2 BLBNB|000882666‏
996 ‎‡2 PTBNP|494268‏
996 ‎‡2 BLBNB|000351346‏
996 ‎‡2 PTBNP|1316392‏
996 ‎‡2 DNB|1056539917‏
996 ‎‡2 BLBNB|000540026‏
996 ‎‡2 LC|n 93007838‏
996 ‎‡2 PTBNP|1839630‏
996 ‎‡2 PTBNP|181165‏
996 ‎‡2 BLBNB|000665468‏
996 ‎‡2 ISNI|000000003825586X‏
996 ‎‡2 DNB|1296372693‏
996 ‎‡2 BLBNB|001511297‏
996 ‎‡2 ISNI|0000000076415801‏
996 ‎‡2 PTBNP|213812‏
996 ‎‡2 PTBNP|195731‏
996 ‎‡2 PTBNP|213810‏
996 ‎‡2 BLBNB|000437313‏
996 ‎‡2 LC|n 97910019‏
996 ‎‡2 PTBNP|1043016‏
996 ‎‡2 PTBNP|237885‏
996 ‎‡2 ISNI|0000000070116456‏
996 ‎‡2 ISNI|0000000070944032‏
996 ‎‡2 DNB|1276148305‏
996 ‎‡2 ISNI|0000000416850042‏
996 ‎‡2 ISNI|0000000070134451‏
996 ‎‡2 LC|no2009069612‏
996 ‎‡2 ISNI|0000000069016394‏
996 ‎‡2 ISNI|0000000069107616‏
996 ‎‡2 ISNI|0000000069413648‏
996 ‎‡2 ISNI|0000000069095571‏
996 ‎‡2 BLBNB|001576032‏
996 ‎‡2 PTBNP|1475752‏
996 ‎‡2 ISNI|0000000054261805‏
996 ‎‡2 LC|no2015150297‏
996 ‎‡2 BLBNB|000508028‏
996 ‎‡2 PTBNP|1183173‏
996 ‎‡2 DNB|1056720816‏
996 ‎‡2 PTBNP|1176376‏
996 ‎‡2 PTBNP|61592‏
996 ‎‡2 ISNI|0000000060705935‏
996 ‎‡2 ISNI|0000000023395333‏
996 ‎‡2 SUDOC|221792945‏
996 ‎‡2 PTBNP|1710614‏
996 ‎‡2 ISNI|0000000068400140‏
996 ‎‡2 PTBNP|1508358‏
996 ‎‡2 PTBNP|1362227‏
996 ‎‡2 BNF|15532328‏
996 ‎‡2 ISNI|0000000024715730‏
996 ‎‡2 DNB|1170625738‏
996 ‎‡2 PTBNP|194753‏
996 ‎‡2 LC|n 2014205664‏
996 ‎‡2 DNB|1274121647‏
996 ‎‡2 PTBNP|1622958‏
996 ‎‡2 BLBNB|001532166‏
996 ‎‡2 BLBNB|000441296‏
996 ‎‡2 ISNI|0000000373611227‏
996 ‎‡2 ISNI|0000000069426959‏
996 ‎‡2 BLBNB|001518714‏
996 ‎‡2 LC|n 79144306‏
996 ‎‡2 BNF|16550348‏
996 ‎‡2 PTBNP|1405097‏
996 ‎‡2 ISNI|0000000110947730‏
996 ‎‡2 LC|nb2017004926‏
996 ‎‡2 PTBNP|184576‏
996 ‎‡2 BLBNB|001566427‏
996 ‎‡2 BLBNB|000482749‏
996 ‎‡2 ISNI|0000000070622842‏
996 ‎‡2 SUDOC|078667429‏
996 ‎‡2 SUDOC|199472785‏
996 ‎‡2 SUDOC|113836139‏
996 ‎‡2 PTBNP|1308478‏
996 ‎‡2 PTBNP|1266865‏
996 ‎‡2 DNB|1057384925‏
996 ‎‡2 PTBNP|942758‏
996 ‎‡2 SELIBR|377577‏
996 ‎‡2 RERO|A003140845‏
996 ‎‡2 PTBNP|1615749‏
996 ‎‡2 NTA|183657454‏
996 ‎‡2 LC|no2015045158‏
996 ‎‡2 LC|nb 99062093‏
996 ‎‡2 LC|n 98911123‏
996 ‎‡2 LC|no2010085934‏
996 ‎‡2 DNB|108145170X‏
996 ‎‡2 PTBNP|1718312‏
996 ‎‡2 PTBNP|1827173‏
996 ‎‡2 ISNI|0000000070936438‏
996 ‎‡2 LC|n 98035065‏
996 ‎‡2 ISNI|0000000123720578‏
996 ‎‡2 BLBNB|000512947‏
996 ‎‡2 PTBNP|1718985‏
996 ‎‡2 ISNI|0000000067545727‏
996 ‎‡2 ISNI|0000000069499058‏
996 ‎‡2 ISNI|0000000428244189‏
996 ‎‡2 BNE|XX5715026‏
996 ‎‡2 PTBNP|193304‏
996 ‎‡2 ISNI|0000000068580962‏
996 ‎‡2 ISNI|0000000070118697‏
996 ‎‡2 DNB|1251490654‏
996 ‎‡2 LIH|LNB:B_h_3G;=BK‏
996 ‎‡2 PTBNP|1318991‏
996 ‎‡2 PLWABN|9811568396205606‏
996 ‎‡2 BLBNB|000354190‏
996 ‎‡2 PTBNP|1778469‏
996 ‎‡2 DNB|1057655449‏
996 ‎‡2 LC|n 2010202734‏
996 ‎‡2 ISNI|0000000069105733‏
996 ‎‡2 BLBNB|000165166‏
996 ‎‡2 DNB|1344615937‏
996 ‎‡2 ISNI|0000000070027963‏
996 ‎‡2 PTBNP|240798‏
996 ‎‡2 SUDOC|270432574‏
996 ‎‡2 BLBNB|001039129‏
996 ‎‡2 DNB|1311756965‏
996 ‎‡2 RERO|A023702676‏
996 ‎‡2 PTBNP|1838325‏
996 ‎‡2 PTBNP|967188‏
996 ‎‡2 PTBNP|134609‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏